Target intelligence / Profile preview

Antigen-presenting cell uptake machinery

Molecular classification
Receptor, Other
01

Overview

The antigen-presenting cell (APC) uptake machinery is a collective term for the diverse array of receptors and endocytic pathways employed by professional APCs, such as dendritic cells, macrophages, and B cells, to internalize exogenous antigens. This machinery includes several specialized receptor families, most notably C-type lectin receptors (e.g., DEC-205, DC-SIGN, and the Mannose Receptor), Fc receptors, and scavenger receptors, which recognize pathogen-associated molecular patterns or opsonized particles. Once internalized via mechanisms like receptor-mediated endocytosis, phagocytosis, or macropinocytosis, antigens are directed into the endolysosomal pathway for proteolytic degradation into peptides. These peptides are subsequently loaded onto MHC class I or II molecules for presentation to T cells, a critical step in the initiation of adaptive immune responses. In therapeutic contexts, this machinery is targeted by vaccines and immunotherapies to enhance antigen delivery and immune activation. For example, antibody-antigen conjugates target specific uptake receptors like DEC-205 to ensure efficient T-cell priming, while lipid nanoparticle-based mRNA vaccines rely on these pathways for cellular entry and subsequent protein expression. Dysregulation or evasion of the APC uptake machinery is a common feature in cancer and chronic infections, where reduced antigen internalization contributes to immune subversion. Conversely, over-activation or inappropriate targeting of these pathways can lead to hypersensitivity or autoimmune reactions.

Other names
Antigen uptake systemAPC internalization pathwaysEndocytic machinery of professional APCsPhagocytic machineryAntigen capture machinery
02

Mechanism of action

Facilitation of antigen internalization via receptor-mediated endocytosis, phagocytosis, or macropinocytosis, followed by intracellular processing and MHC-mediated presentation to T cells.

03

Biological functions

Immune responseAntigen processing and presentationEndocytosisPhagocytosisPinocytosisCell signaling
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Cytokine release syndromeOff-target uptake by non-immune cellsInduction of immune toleranceAutoimmunityInjection site reactions
06

Interacting drugs

CDX-1401

6 more in the full profile.

07

Biomarkers

CD80 expressionCD86 expressionCD40 expressionHLA-DR expressionIFN-gamma productionIL-12 production

Beyond the preview

Go deeper on Antigen-presenting cell uptake machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell uptake machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call